Investors Research Corp’s Genesis Healthcare, Inc. GEN Stock Holding History

Investors Research Corp’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,000	Closed	-$1K	–	1124
2020 Q3	$1K	Hold	2,000	–	–	﹤0.01%	1078
2020 Q2	$1K	Hold	2,000	–	–	﹤0.01%	1071
2020 Q1	$2K	Hold	2,000	–	–	﹤0.01%	1049
2019 Q4	$3K	Hold	2,000	–	–	﹤0.01%	1012
2019 Q3	$2K	Hold	2,000	–	–	﹤0.01%	1051
2019 Q2	$2K	Hold	2,000	–	–	﹤0.01%	1005
2019 Q1	$3K	Buy	+2,000	New	+$2.96K	﹤0.01%	928

Other funds holding GEN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Investors Research Corp's GEN Position: Q4 2020 in Review

Investors Research Corp sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 2,000 shares — an estimated $1K sold.

Investors Research Corp first reported a position in GEN in Q1 2019 and held it in 7 quarters. The position peaked at $3K in Q4 2019. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.

Investors Research Corp reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
Investors Research Corp sold 2,000 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $1K.
Investors Research Corp first reported a position in Genesis Healthcare, Inc. in Q1 2019 and held it in 7 quarters.
Investors Research Corp's Genesis Healthcare, Inc. position peaked at $3K in Q4 2019.
49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.

Based on Investors Research Corp's 13F filing for Q4 2020, filed 21 Jan 2021.